Shannon Dwinnell

Clinical Assistant Professor

Department of Obstetrics & Gynecology - Division of Maternal-fetal Medicine

BSc - Honors Biology - Genetics

University of Western Ontario - 1996

MD

University of British Columbia, Faculty of Medicine - 2003

FRCSC - Obstetrics and Gynecology

University of Calgary -, 2008

NICHD-IHDCYH 6th Summer Institute in Maternal Fetal Pharmacology

St. Michaels, Maryland, USA - 2010

Subspecialty Fellow in Surgery, Maternal Fetal Medicine (FRCSC)

University of British Columbia - 2011


Contact information

Phone

Clinic: 403-210-8030

Research and teaching

Areas of Interest

Complicated Obstetrics

Maternal cardiac disease multidisciplinary clinical care

Abnormally invasive placenta (AIP) – imaging & multidisciplinary care

Fetal diagnosis & therapy

Maternal-Fetal Pharmacology

Implementation of preeclampsia screening and prevention


Biography

Shannon Dwinnell is an Obstetrician – Maternal Fetal Medicine (MFM) specialist based at Foothills Medical Centre and Calgary MFM Centre.  Clinical interests include streamlining care in complicated Obstetrics, particularly in the areas of maternal cardiac disease, abnormally invasive placentation (AIP) and fetal anomalies. She has an interest in prenatal diagnosis and therapy and is currently an active member of the provincial AHS-MFM Fetal Therapy team and the Genetics Committee for the Society of Obstetricians & Gynecologists of Canada (SOGC). She is also a reviewer for the Calgary AHS-MFM quality assurance (QA) committee and an examination quality reviewer for the Royal College of Physicians & Surgeons (RCPSC) MFM Fellowship Subspecialty Examination committee.  Current research areas of interest include implementation of preeclampsia screening & prevention (IMPRESS) and evaluating outcomes of pregnancies complicated by abnormal placentation.


Publications

Halperin, S et al. A randomized, controlled trial of the safety and immunogenicity of tetanus, diphtheria and acellular pertussis vaccine (Tdap) immunization during pregnancy and subsequent infant immune response. Clin Infect Dis (2018) 67(7): 1063.

 

S Ross, J Milne, S Dwinnell, S Tang, S Wood. Is it possible to estimate clinically important treatment effect needed to change practice in preterm birth prevention? Results of an obstetrician survey used to support the design of a trial. BMC Med Res Methodol (2012) 12: 31.

 

P von Dadelszen, K Lim, S Dwinnell, LA Magee, B Carleton, A Gruslin, B Lee, RM Liston, S Miller, BA Payne, D Rurak, R Sherlock, MA Skoll, M Wareing, PN Baker. Reversed umbilical arterial end diastolic flow, sildenafil treatment and early stillbirths. BJOG (2012) 119(4): 510.

 

P von Dadelszen, SJ Dwinnell, LA Magee, PN Baker, B Carleton, A Gruslin, B Lee, K Lim, RM Liston, S Miller, BA Payne, D Rurak, R Sherlock, MA Skoll, M Wareing. Sildenafil citrate therapy for early-onset severe intrauterine growth restriction.  BJOG (2011) 118(5): 624.

 

SJ Dwinnell, S Coad, B Butler, SG Albersheim, L Wadsworth, JK Wu, MF Delisle. In utero diagnosis and management of a fetus with homozygous alpha-thalassemia in the second trimester. A case report and literature review. J Pediatr Hematol Oncol (2011) 33(8): 358.
 

DM Pillers, JB Kempton, NM Duncan, J Pang, SJ Dwinnell, DR Trune. Hearing loss in the Laminin-deficient dy mouse model of congenital muscular dystrophy. Mol Genet Metab (2002) 76(3): 217.

 

DM Pillers, NM Duncan, SJ Dwinnell, SM Rash, JB Kempton, DR Trune. Normal cochlear function in mdx and mdxCv3 Duchenne muscular dystrophy mouse models. Laryngoscope (1999) 109(8): 1310.

 

DM Pillers, DM Fitzgerald, NM Duncan, SM Rash, SJ Dwinnell, RA White, BR Powell, RE Schnur, PN Ray, GW Cibis, RG Weleber. Duchenne/Becker muscular dystrophy: correlation of phenotype by electroretinography with sites of dystrophin mutations. Hum Genet (1999) 105: 2.